BCV
ALXN

Banque Cantonale Vaudoise’s Alexion Pharmaceuticals ALXN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-131
Closed -$24K – 1387
2021
Q2 		$24K Sell
131
-48
-27% -$8.24K ﹤0.01% 1148
2021
Q1 		$27K Sell
179
-3,123
-95% -$483K ﹤0.01% 1057
2020
Q4 		$515K Sell
3,302
-2,263
-41% -$291K 0.03% 487
2020
Q3 		$636K Buy
5,565
+438
+9% +$47.3K 0.04% 375
2020
Q2 		$576K Buy
5,127
+790
+18% +$83.9K 0.04% 353
2020
Q1 		$388K Sell
4,337
-68
-2% -$6.67K 0.03% 429
2019
Q4 		$476K Buy
+4,405
New +$471K 0.03% 480

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Banque Cantonale Vaudoise's ALXN Position: Q3 2021 in Review

Banque Cantonale Vaudoise sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 131 shares — an estimated $24K sold.

Banque Cantonale Vaudoise first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $636K in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Banque Cantonale Vaudoise reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 131 Alexion Pharmaceuticals shares in Q3 2021, an estimated $24K.
  • Banque Cantonale Vaudoise first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Banque Cantonale Vaudoise's Alexion Pharmaceuticals position peaked at $636K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2021, filed 29 Oct 2021.